E-LIB Suche - Ergebnisse für: Fish, Susan

1

Mary of Bethany: Creation through Conversation:

Fish, Susan
Religions. 15 (2024) 4 - p. 411 , 2024

2

P-263 Treatment patterns and clinical outcomes in multiple ..:

Goldschmidt, Hartmut ; Vij, Ravi ; Kuter, David...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S180-S181 , 2023

Link: https://doi.org/10.1016/..

3

P-299 Survival outcomes in older patients with relapsed/ref..:

Moreau, Philippe ; Vij, Ravi ; Goldschmidt, Hartmut...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S202-S203 , 2023

Link: https://doi.org/10.1016/..

4

P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOS..:

Ramasamy, Karthik ; Goldschmidt, Hartmut ; Moreau, Philippe...
HemaSphere. 7 (2023) S3 - p. e642555a , 2023

Link: https://doi.org/10.1097/..

5

The Value of Pharmaceutical Industry-Sponsored Patient Regi..:

Flick, E Dawn ; Terebelo, Howard R ; Fish, Susan...
The Oncologist. 28 (2023) 8 - p. 657-663 , 2023

Link: https://doi.org/10.1093/..

6

Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-0682664..:

Gerstenberger, Brian S. ; Ambler, Catherine ; Arnold, Eric P....
Journal of Medicinal Chemistry. 63 (2020) 22 - p. 13561-13577 , 2020

Link: https://doi.org/10.1021/..

7

Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-me..:

Schnute, Mark E. ; Wennerstål, Mattias ; Alley, Jennifer...
Journal of Medicinal Chemistry. 61 (2018) 23 - p. 10415-10439 , 2018

Link: https://doi.org/10.1021/..

8

Effectiveness of bevacizumab exposure beyond disease progre..:

Leon, Larry ; Kosty, Michael ; Jahanzeb, Mohammad...
Pharmacoepidemiology and Drug Safety. 25 (2016) 5 - p. 569-577 , 2016

Link: https://doi.org/10.1002/..

9

Effectiveness and safety of post-induction phase bevacizuma..:

Kosty, Michael P. ; Wozniak, Antoinette J. ; Jahanzeb, Mohammad...
Targeted Oncology. 10 (2015) 4 - p. 509-516 , 2015

Link: https://doi.org/10.1007/..

10

Discovery of Isoquinolinone Indole Acetic Acids as Antagoni..:

Kaila, Neelu ; Follows, Bruce ; Leung, Louis...
Journal of Medicinal Chemistry. 57 (2014) 4 - p. 1299-1322 , 2014

Link: https://doi.org/10.1021/..

11

Bevacizumab exposure beyond first disease progression in pa..:

Grothey, Axel ; Flick, E. Dawn ; Cohn, Allen L....
Pharmacoepidemiology and Drug Safety. 23 (2014) 7 - p. 726-734 , 2014

Link: https://doi.org/10.1002/..

12

Therapeutic activity of an interleukin‐4/interleukin‐13 dua..:

Kasaian, Marion T. ; Page, Karen M. ; Fish, Susan...
Immunology. 143 (2014) 3 - p. 416-427 , 2014

Link: https://doi.org/10.1111/..

13

Discovery of potent and selective matrix metalloprotease 12..:

Wu, Yuchuan ; Li, Jianchang ; Wu, Junjun...
Bioorganic & Medicinal Chemistry Letters. 22 (2012) 1 - p. 138-143 , 2012

Link: https://doi.org/10.1016/..

14

Diazine Indole Acetic Acids as Potent, Selective, and Orall..:

Kaila, Neelu ; Huang, Adrian ; Moretto, Alessandro...
Journal of Medicinal Chemistry. 55 (2012) 11 - p. 5088-5109 , 2012

Link: https://doi.org/10.1021/..

15

Treatment Patterns and Clinical Outcomes in Patients With M..:

Bendell, Johanna C. ; Bekaii-Saab, Tanios S. ; Cohn, Allen L....
The Oncologist. 17 (2012) 12 - p. 1486-1495 , 2012

Link: https://doi.org/10.1634/..